Notably, HCC with high expression of APOA2 relied on TGF-β to promote cell proliferation and angiogenesis, and pharmacological loss of TGF-β function can reduce angiogenesis and malignant tumor proliferation. Here, APOA2 is linked to hepatocellular carcinoma.